1. S. G. Burchinskii, “Neuroleptics in the pharmacotherapy of bipolar affective disorders: selection possibilities,” NeiroNEWS (electronic), 4, No. 15 (2009).
2. V. A. Otellin, L. I. Khozhai, and N. E. Ordyan, Prenatal Stressors and the Developing Brain. Adaptive Mechanisms, Direct and Delayed Effects [in Russian], Desyatka, St. Petersburg (2007).
3. J. Bell III, X. N. Zhang, and P. M. Whitaker-Azmitia, “5-HT3 receptor-active drugs alter development of spinal serotoninergic innervation: lack of effect of other serotonergic agents,” Brain Res., 571, No. 2, 293–297 (1992).
4. I. P. Butkevich, V. A. Mikhailenko, L. I. Khozhai, and V. A. Otellin, “Pain sensitivity during ontogeny and long-term effects of prenatal noxious events,” in: Perinatal Programming. Early Life Determinants of Adult Health and Disease, Taylor & Francis, London, New York (2006), pp. 211–222.
5. I. P. Butkevich, V. A. Mikhailenko, E. A. Vershinina, L. I. Khozhai, I. P. Grigorev, and V. A. Otellin, “Reduced serotonin synthesis during early embryogeny changes effect of subsequent prenatal stress on persistent pain in the formalin test in adult male and female rats,” Brain Res., 1042, No. 2, 144–159 (2005).